Sepsis kills, and diagnosis is too slow.
The RADOS project (@inbiome + @MaastrichtUMC + @Philips) aims for: faster diagnosis = Better treatment, lower mortality & AMR.
Early ICU results discussed at latest RADOS meeting look promising—see them at @NVMM_NL 2025 conference!
🧪 Certified fresh! (Well, ISO 13485:2016 fresh 😉)
Inbiome’s quality management system is officially re-certified through 2028! ✅
Quality is our foundation, and this milestone reflects our commitment to reliable, safe diagnostics.
Huge thanks to our team! 👏
#Inbiome#ISO13485
👏 Huge shoutout to one of our latest interns, Maaike Oudman!
She just graduated with a thesis on one of Inbiome’s newest assays—one that could make diagnosing infectious diseases smarter & faster. 🦠⚡
Congrats, Maaike! We’re proud & grateful for your contributions! 🚀
#Inbiome
We’re pleased to be included in @Iamsterdam’s list of Healthcare & MedTech Companies to Watch!
Read about the MedTech innovation happening in Amsterdam: https://t.co/OVAr0dE8fk
#MedTech#Healthcare#Innovation#InBiome
🧬🦠 Publication alert! inbiome recently participated in two studies exploring the best and easiest methods to sample the urogenital microbiota for diagnostics.
You may read them here: https://t.co/UuMPw8Z3M9 https://t.co/6DCdIeoqcO
The protocol of our collaborative neonatal sepsis study CHAMPIONS is out https://t.co/rwShZyfFjE
What is the study goal? To help clinicians quickly figure out which babies need antibiotics and which don’t, minimizing unnecessary treatments and keeping those tiny guts healthy.
🎓 Exciting News from the inbiome Team! 🎓
We are proud to announce that two of our talented team members, Frane and Maria, have completed their Masters of Science (MSc)in Bioinformatics and Systems Biology!
#inbiome#HealthcareInnovation#MScGraduates
Congratulations to our Delft University of Technology JIP team for their innovative work in the Joint Interdisciplinary Project with #inbiome.
Your contribution to rapid bacterial diagnostics using capillary electrophoresis has the potential to make a meaningful impact!
🌟 Welcome to inbiome!🌟
We're excited to introduce our new intern Elise!
Elise brings fresh perspective and enthusiasm to our team. Her passion for innovative solutions in healthcare will be a valuable asset as she collaborates on our research projects. Enjoy!
🎃 🦠 When you’re out trick-or-treating, remember that the most fascinating creatures might be invisible to the naked eye! Remember, not all heroes wear capes; some wear lab coats. May your discoveries be as exciting as the thrill of a haunted house. 👻#inbiome#Halloween
📢 #Inbiome will be present at the 41st Annual Meeting of the European Bone and Joint Infection Society! 🦴As pioneers in our field, we'd love to connect to explore collaboration and partnership opportunities. 🔍🤝
#EBJIS2023#EBJIS #Collaboration#Partnership#MolecularCulture
Last week, our team embarked on a vibrant journey to explore the world of street art graffiti.
We've narrowed down our artwork to 2 top creations. Which one resonates with you the most?
#inbiome#TeamCreativity#PicassoVibes
#GutMicrobiota as an early biomarker for Late Onset #Sepsis? New paper in the Clinical Infectious Diseases journal that uses @inBiome's IS-pro to study the role of intestinal microbiota in the pathogenesis of late onset sepsis (LOS) in preterm infants https://t.co/0z9jPVgjg8
inBiome researchers identify a throat microbiota profile which seems protective against COVID19 and occurs mainly in the young. Preprint now available:
An age dependent pharyngeal microbiota signature associated with SARS-CoV-2 infection @SSRN https://t.co/2FFVbOZQ5h
So proud to have been nominated for and to win the public prize for best Health Innovation in Amsterdam 2020!
Thank you to @smarthealthams, @AmEcBoard & @Zorg_innovatie for your support. These events are critical for companies like ours to get vital exposure! 🤞@VitaValley